Myriad Genetics (MYGN) Stock Price, Quote, News & History | Benzinga

Myriad Genetics Inc (MYGN) Stock Price, Quote, News & History

MYGNNASDAQ

Trade with Public

Trade with Public

$3.20

-0.02-0.62%

At close: Aug 21, 5:00 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$3.22

Close

$3.20

Volume / Avg.

1.28M / 1.91M

Day Range

$3.12 - $3.26

52 Wk Range

2.74 - 8.59

Market Cap

$302.23M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

35

Short Interest

9.22%

Days to Cover

3.91

Recent Myriad Genetics, Inc. News

Crude Oil Gains 1%; Apple Shares Tumble After Q3 Results

Dow up 0.38%, NASDAQ up 0.25%, S&P 500 up 0.22%. Consumer discretionary shares up 5.6%, materials stocks down 2.7%. Apple beats estimates, shares down 9%.

Avi Kapoor

Apple, Stryker, Coinbase And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

U.S. stock futures rise, Nasdaq 100 up 300 points. Apple Inc shares fall 7.4% despite beating analyst estimates for Q3. Other stocks also dip in pre-market.

Avi Kapoor

Why Amazon Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket

Amazon reported strong Q2 results, beating revenue and earnings estimates. Shares jumped 11.9% in pre-market trading while other stocks also saw gains/losses.

Avi Kapoor

Myriad Genetics Stock Drops Sharply After Hours: What Investors Need to Know

Myriad Genetics stock fell after hours after weak Q2 results, lower guidance and an operating loss.

Tanya Rawat

Why Keysight Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

7.70M

Investing Cash Flow (TTM)

-21.90M

Financing Cash Flow (TTM)

47.20M

Free Cash Flow (TTM)

-14.20M

Capital Expenditure (TTM)

-21.90M

Net Change in Cash (TTM)

33.00M

Analyst Trends and Forecast

2

Feb

1

May

0

0

0

0

Jul

2

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

1.8

Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$401.38M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

0.37

PB Ratio (TTM)

1.01

Earnings Yield % (TTM)

-36.65%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$3.18

Company Debt

Total Debt

$120.70M

LT Debt

$120.70M

LT Debt Issuance (TTM)

$125.00M

LT Debt Repayment (TTM)

-$60.30M

Total Cash

$115.20M

Debt to Equity

0.69

Issuance of Debt (TTM)

$64.70M

Repayment of Debt (TTM)

-$60.30M

Key Statistics

Open

$3.22

Close

$3.20

Volume / Avg.

1.28M / 1.91M

Day Range

$3.12 - $3.26

52 Wk Range

2.74 - 8.59

Market Cap

$302.23M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

35

Short Interest

9.22%

Days to Cover

3.91

About

Sector

Health Care

Industry

Biotechnology

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Myriad Genetics (MYGN) stock?

A

You can purchase shares of Myriad Genetics (NASDAQ:MYGN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Myriad Genetics (MYGN) competitors?

A

Other companies in Myriad Genetics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Myriad Genetics (MYGN) stock?

A

Myriad Genetics has a consensus price target of $12.17.

Q

What is the current price for Myriad Genetics (MYGN)?

A

The stock price for Myriad Genetics (NASDAQ: MYGN) is $3.2 last updated August 21, 2026 at 4:00 PM EDT.

Q

Does Myriad Genetics (MYGN) pay a dividend?

A

There are no upcoming dividends for Myriad Genetics.

Q

When is Myriad Genetics (NASDAQ:MYGN) reporting earnings?

A

Myriad Genetics does not have any upcoming earnings scheduled.

Q

Is Myriad Genetics (MYGN) going to split?

A

There is no upcoming split for Myriad Genetics.

Q

What sector and industry does Myriad Genetics (MYGN) operate in?

A

Myriad Genetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.